Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Statin therapy in a kindred with both apolipoprotein B and low density lipoprotein receptor gene defects.

Atherosclerosis - 28 Feb 1997

Raal F J, Pilcher G, Rubinsztein D C, Lingenhel A, Utermann G

Abstract excerpt

We studied an extended family of similar genetic and environmental background to determine whether there is a difference in response to statin therapy in those subjects with heterozygous familial hypercholesterolaemia (FH Afrikaner-1 (FH1) or FH Afrikaner-2 (FH2)) compared to those with familial defective apo B-100 (FDB), or both FH plus FDB. Fasting lipid profiles and Lp(a) levels were done on 18 members of the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apolipoproteins A
Share to Apolipoproteins B
Share to Child, Preschool

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Follow-Up Studies

Share to Heterozygote

Share to Hyperlipoproteinemia Type II

Share to Immunoblotting

Share to Pedigree

Source

Identifiers

PMID: 9069523
DOI: 10.1016/s0021-9150(96)06007-8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Statin therapy in a kindred with both apolipoprotein B and low density lipoprotein receptor gene defects.PMID 9069523Read ↗

Monogenic primary hypercholesterolaemia in South Africa.Semantic proximity Read ↗

Response to cholesterol-lowering drugs in familial defective apolipoprotein B-100.Semantic proximity Read ↗

Phenotypic variation among familial hypercholesterolemics heterozygous for either one of two Afrikaner founder LDL receptor mutations.Semantic proximity Read ↗

Genetic and environmental factors affecting the response to statin therapy in patients with molecularly defined familial hypercholesterolaemia.Semantic proximity Read ↗

Characterization of six patients who are double heterozygotes for familial hypercholesterolemia and familial defective apo B-100.Semantic proximity Read ↗

Low density lipoprotein kinetics in a family having defective low density lipoprotein receptors in which hypercholesterolemia is suppressed.Semantic proximity Read ↗

Determinants of variable response to statin treatment in patients with refractory familial hypercholesterolemia.Semantic proximity Read ↗

Hypolipidemic treatment of heterozygous familial hypercholesterolemia: a lifelong challenge.Semantic proximity Read ↗

Serum lipoprotein(a) in patients heterozygous for familial hypercholesterolemia, their relatives, and unrelated control populations.Semantic proximity Read ↗

Response to drugs and diet in a compound heterozygote for familial hypercholesterolaemia.Semantic proximity Read ↗

Familial defective apolipoprotein B-100: a review, including some comparisons with familial hypercholesterolaemia.Semantic proximity Read ↗

Effect of ezetimibe coadministered with statins in genotype-confirmed heterozygous FH patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.